GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Dividend Yield %

Roquefort Therapeutics (LSE:ROQ) Dividend Yield % : 0.00% (As of Jun. 10, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Dividend Yield %?

As of today (2024-06-10), the Trailing Annual Dividend Yield of Roquefort Therapeutics is 0.00%.

The historical rank and industry rank for Roquefort Therapeutics's Dividend Yield % or its related term are showing as below:

LSE:ROQ's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful Dividend Yield % only.

Roquefort Therapeutics's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-06-10), the Forward Dividend Yield % of Roquefort Therapeutics is 0.00%.

Roquefort Therapeutics's Dividends per Share for the six months ended in Dec. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Roquefort Therapeutics Dividend Yield % Historical Data

The historical data trend for Roquefort Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Dividend Yield % Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Dividend Yield %
- - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23
Dividend Yield % - - - - -

Competitive Comparison of Roquefort Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Roquefort Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roquefort Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's Dividend Yield % falls into.



Roquefort Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Roquefort Therapeutics  (LSE:ROQ) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Roquefort Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Roquefort Therapeutics (LSE:ROQ) Business Description

Traded in Other Exchanges
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines